Arabic Arabic English English French French German German
dark

GSK and Vir Biotechnology announce United States government agreement to purchase additional supply of sotrovimab

GlaxoSmithKlineGlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) announced that the US Government will purchase an additional 600,000 doses of sotrovimab, an investigational monoclonal antibody for the early treatment of COVID-19, enabling further nationwide access to sotrovimab for patients.

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Testing company marks 20th anniversary with several gongs

Next Post

Masks rules get tighter in Europe in winter’s COVID-19 wave

Related Posts
Total
0
Share